ROYAL BANK OF CANADA - IMMUNOVANT INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$1,537,000
+1751.8%
40,041
+820.7%
0.00%
Q2 2023$83,000
+38.3%
4,349
+12.1%
0.00%
Q1 2023$60,000
-45.0%
3,879
-37.2%
0.00%
Q4 2022$109,000
+1111.1%
6,176
+300.8%
0.00%
Q3 2022$9,000
+80.0%
1,541
+21.7%
0.00%
Q2 2022$5,000
-75.0%
1,266
-64.2%
0.00%
Q1 2022$20,000
-73.0%
3,533
-59.0%
0.00%
Q4 2021$74,000
+94.7%
8,626
+96.1%
0.00%
Q3 2021$38,000
+15.2%
4,398
+41.5%
0.00%
Q2 2021$33,000
-13.2%
3,109
+32.2%
0.00%
Q1 2021$38,000
-59.6%
2,351
+15.5%
0.00%
Q4 2020$94,000
+56.7%
2,035
+20.3%
0.00%
Q3 2020$60,000
+5900.0%
1,691
+3926.2%
0.00%
Q2 2020$1,000420.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 1,439,544$22,327,3278.67%
Logos Global Management LP 2,500,000$38,775,0005.55%
Deep Track Capital, LP 7,432,717$115,281,4414.74%
COMMODORE CAPITAL LP 1,440,999$22,349,8943.40%
Ikarian Capital, LLC 774,398$12,010,9132.72%
COWEN AND COMPANY, LLC 1,250,000$19,387,5002.28%
HighVista Strategies LLC 163,799$2,540,5222.07%
TCG Crossover Management, LLC 654,853$10,156,7701.98%
BVF INC/IL 2,561,000$39,721,1101.45%
Redmile Group, LLC 1,317,031$20,427,1510.89%
View complete list of IMMUNOVANT INC shareholders